Title:
SARS-COV-2 ADSORPTION CARRIER AND COLUMN CONTAINING THIS
Document Type and Number:
WIPO Patent Application WO/2022/004707
Kind Code:
A1
Abstract:
The present invention provides a partial peptide of angiotensin-converting enzyme (ACE2), a carrier where said peptide is fixed, and a column containing said carrier.
Inventors:
ISAKA YOSHITAKA (JP)
MATSUURA YOSHIHARU (JP)
YOSHIYA TAKU (JP)
MATSUURA YOSHIHARU (JP)
YOSHIYA TAKU (JP)
Application Number:
PCT/JP2021/024503
Publication Date:
January 06, 2022
Filing Date:
June 29, 2021
Export Citation:
Assignee:
UNIV OSAKA (JP)
PEPTIDE INST INC (JP)
PEPTIDE INST INC (JP)
International Classes:
C07K14/47; C12M1/40; C12N11/08; C12N11/14
Foreign References:
| JP2009524420A | 2009-07-02 | |||
| JP2004516896A | 2004-06-10 |
Other References:
HAN, YANXIAO ET AL.: "Computational Design of ACE2-Based Peptide Inhibitors of SARS-CoV-2", ACS NANO, vol. 14, no. 4, 14 April 2020 (2020-04-14), pages 5143 - 5147, XP055732485, DOI: 10.1021/acsnano.0c02857
TEMEL, SAHIN ET AL.: "Blood Purification Treatments in COVID-19", J. CRI. INT. CARE, vol. 11, no. 1, 22 June 2020 (2020-06-22), pages 32 - 35, XP055895932
SAURABH, SUMAN ET AL.: "A Modified ACE2 peptide mimic to block SARS-CoV2 entry", BIORXIV, 8 May 2020 (2020-05-08), XP055799138, Retrieved from the Internet [retrieved on 20210810], DOI: https://doi.org/10.1101/ 2020.05.07.082230
TEMEL, SAHIN ET AL.: "Blood Purification Treatments in COVID-19", J. CRI. INT. CARE, vol. 11, no. 1, 22 June 2020 (2020-06-22), pages 32 - 35, XP055895932
SAURABH, SUMAN ET AL.: "A Modified ACE2 peptide mimic to block SARS-CoV2 entry", BIORXIV, 8 May 2020 (2020-05-08), XP055799138, Retrieved from the Internet
Attorney, Agent or Firm:
YAMAO, Norihito et al. (JP)
Download PDF: